An internal standard for the quantification of fluconazole
Related Products
Unlabeled Version(s)
11594Fluconazole
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Fluconazole-d4

Item No. 18252

Technical Information
Formal Name
α-(2,4-difluorophenyl)-α-(1H-1,2,4-triazol-1-ylmethyl-d2)-1H-1,2,4-triazole-1-ethan-β,β-d2-ol
CAS Number
1124197-58-5
Molecular Formula
C13H8D4F2N6O
Formula Weight
Purity
≥99% deuterated forms (d1-d4)
A solid
DMSO: SolubleEthanol: Soluble
SMILES
FC1=CC(F)=C(C(C([2H])([2H])N2C=NC=N2)(O)C([2H])([2H])N3C=NC=N3)C=C1
InChi Code
InChI=1S/C13H12F2N6O/c14-10-1-2-11(12(15)3-10)13(22,4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3,6-9,22H,4-5H2/i4D2,5D2
InChi Key
RFHAOTPXVQNOHP-CQOLUAMGSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Cayman Chemical
    Neutrophil Biology Wall Poster

    Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.

    DOWNLOAD NOW
    Product Description

    Fluconazole-d4 is intended for use as an internal standard for the quantification of fluconazole (Item No. 11594) by GC- or LC-MS. Fluconazole is a triazole antifungal agent that is effective against most Candida strains.1 In vivo, fluconazole at 0.5-100 mg/kg demonstrates protective activity in various experimental animal models of systemic fungal diseases including aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, cryptococcosis, and histoplasmosis.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Herbrecht, R., Nivoix, Y., Fohrer, C., et alManagement of systemic fungal infections: Alternatives to itraconazole. J. Antimicrob. Chemother. 56(Suppl 1), i39-i48 (2005).

    2. Saag, M.S., and Dismukes, W.E. Azole antifungal agents: Emphasis on new triazoles. Antimicrob. Agents Chemother. 32(1), 1-8 (1988).